Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04TJL
|
|||
| Former ID |
DIB006899
|
|||
| Drug Name |
LAS-41004
|
|||
| Synonyms |
Anti-inflammatory (psoriasis/atopic dermatitis), Almirall
Click to Show/Hide
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 2 | [1] | |
| Company |
Almirall Prodesfarma SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01119339) Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.